The changing landscape of surgery for prostate cancer

Poster Session 14

  • Location:
    Room Stockholm (Hall B2, level 0)
  • Chairs:
     R. Khauli, Beirut (LB)
     R.E. Sanchez Salas, Paris (FR)
     T. Sulser, Zürich (CH)
  • Aims and objectives of this session

    During this session the trends in surgically treated patients profiles, in morbidity of surgical approaches, in risk of death after radical prostatectomy and in new subclassification systems for our patients will be discussed.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
* 163
Historical trends in high-risk prostate cancer patients characteristics: A 27 years old observational study from the European multicenter prostate cancer clinical and translational research group (EMPaCT) data base

By: Bianchi M.1, Briganti A.2, Karnes J.3, Gandaglia G.2, Fossati N.2, Spahn M.4, Gontero P.5, Tosco L.6, Kneitz B.7, Chun F.8, Zaffuto E.2, De Ridder D.6, Sun M.9, Graefen M.10, Marchioro G.11, Frohneberg D.12, Guilloneau B.13, Giona S.5, Sanchez-Salas R.14, Cathelineau X.14, Karakiewicz P.9, Van Poppel H.6, Montorsi F.2, Joniau S.6

Institutes: 1Magna Graecia University of Catanzaro, Dept. of Urology, Catanzaro, Italy, 2IRCCS Ospedale San Raffaele, Dept. of Oncology and Urology; URI, Milan, Italy, 3Mayo Medical School and Mayo Clinic, Dept. of Urology, Rochester, United States of America, 4University of Berne, Dept. of Urology, Berne, Switzerland, 5University of Turin, Molinette Hospital, Dept. of Urology, Turin, Italy, 6University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 7University Hospital Wurzburg, Dept. of Urology and Pediatric Urology, Wurzburg, Germany, 8University Hospital Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 9University of Montreal Health Center, Dept. of Cancer Prognostics and Health Outcomes, Montreal, Quebec, Canada, 10University Medical Center Hamburg-Eppendorf, Martini-Clinic, Prostate Cancer Centre, Hamburg, Germany, 11University of Piemonte Orientale, Dept. of Urology, Novara, Italy, 12Community Hospital Karlsruhe, Dept. of Urology, Karlsruhe, Germany, 13Memorial Sloan-Kettering Cancer Center, Dept. of Urology Service and Surgery, New York, United States of America, 14Institut Mutualiste Montsouris, Dept. of Urology, Paris, France

Restratification of high risk prostate cancer according to NCCN guideline for patients who underwent radical prostatectomy: Analysis from K-CaP registry

By: Lee K.S.1, Koo K.C.1, Choi I.Y.2, Lee J.Y.3, Hong J.H.4, Kim C-S.4, Lee H.M.5, Hong S.K.6, Rha K.H.7, Chung B.H.7

Institutes: 1Urological Science Institute, Yonsei University College of Medicine, Dept. of Urology, Seoul, South Korea, 2Graduate School of Management and Policy, The Catholic University of Korea, Dept. of Urology, Seoul, South Korea, 3Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Dept. of Urology, Seoul, South Korea, 4Asan Medical Center, University of Ulsan College of Medicine, Dept. of Urology, Seoul, South Korea, 5Samsung Medical Center, Sungkyunkwan University School of Medicine, Dept. of Urology, Seoul, South Korea, 6Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 7Urological Science Institute, Yonsei University College of Medicine, Dept. of Urology, Seongnam, South Korea

National trends and differences in morbidity among surgical approaches for radical prostatectomy in Germany

By: Stolzenburg J.U., Kyriazis I., Gilfrich C., Popken G., Weißbach L., Von Zastrow C., Fahlenbrach C., Günster C., Jeschke E., Leicht H.

Institutes: University of Leizig, Dept. of Urology, Leipzig, Germany

Trend of global quality of life in localized or metastatic prostate cancer patients after treatment: A 5-year Kernel smoothing curve analysis

By: Kao Y-L.1, Tsai Y-S.1, Ou F-Y.1, Lin Z-Y.2, Ou C-H.1, Yang W-H.1, Cheng H-L.1, Tzai T-S.1, Wang J-D.2

Institutes: 1National Cheng Kung University Hospital, Dept. of Urology, Tainan, Taiwan, 2National Cheng Kung University, Dept. of Public Health, Tainan, Taiwan

* 167
Prostate cancer death after radical prostatectomy or radiotherapy: Nationwide population-based study

By: Robinson D.1, Garmo H.2, Franck Lissbrant I.3, Nilsson P.4, Widmark A.5, Stattin P.6

Institutes: 1Ryhov County Hospital, Dept. of Urology, Eksjö, Sweden, 2Uppsala University Hospital, Dept. of Cancer, Uppsala, Sweden, 3Sahlgrenska Academy, Dept. of Oncology, Gothenburg, Sweden, 4Skåne University Hospital, Dept. of Oncology and Radiation Physics, Lund, Sweden, 5Umeå University, Dept. of Radiation Sciences, Umeå, Sweden, 6Umeå University, Dept. of Surgery and Perioperative Sciences, Urology and Andrology, Umeå, Sweden

Pathologic outcomes using different extended templates for lymph node dissection at radical prostatectomy

By: Maderthaner L., Furrer M., Burkhard F., Thalmann G., Studer U., Nguyen D.

Institutes: University Hospital Berne, Dept. of Urology, Berne, Switzerland

Pathological analysis of patients undergoing radical prostatectomy who were potential candidates for focal therapy

By: Oliveira Soares R.M.1, Haagsma B.2, Laing R.3, Patil K.1, Eden C.1, Langley S.1

Institutes: 1Royal Surrey County Hospital, Dept. of Urology, Guildford, United Kingdom, 2Royal Surrey County Hospital, Dept. of Pathology, Guildford, United Kingdom, 3St. Luke’s Cancer Centre, Dept. of Oncology, Guildford, United Kingdom

Hypogonadism independently predicts pathological Gleason pattern 5 at the time of radical prostatectomy

By: Moschini M.1, Dell’Oglio P.1, Fossati N.1, Gandaglia G.1, Larcher A.1, Stabile A.1, Saitta G.1, Ventimiglia E.1, Barbagli G.2, Shariat S.3, Bollens R.4, Montorsi F.1, Briganti A.1

Institutes: 1IRCCS Ospedale San Raffaele, Division of Oncology/Unit of Urology; URI, Milan, Italy, 2Centro Chirurgico Toscano, Dept. of Urology, Arezzo, Italy, 3Medical University of Vienna, Dept. of Urology, Vienna, Austria, 4Jules Bordet Institute, Université Libre De Bruxelles, Dept. of Urology, Brussels, Belgium

Factors improving lymph node invasion detection during pelvic lymph node dissection for prostate cancer: Outcomes of 2160 lymph node dissections

By: Kyriazis I.1, Do M.1, Dietel A.1, Ganzer R.1, Alloussi S.1, Kallidonis P.2, Liatsikos E.2, Stolzenburg J.U.1

Institutes: 1University of Leizig, Dept. of Urology, Leipzig, Germany, 2University of Patras, Dept. of Urology, Patras, Greece

A new sub-classification system for decision making with intermediate risk prostate cancer patients treated by radical prostatectomy: A multicenter study

By: Beauval J.B.1, Ploussard G.2, Ouzzane A.3, Gougeon A.16, Cabarrou B.17, Gas J.1, Marcq G.4, Mathieu R.5, Fromont G.6, Hennequin C.7, Vincendeau S.5, Renard Penna R.8, Azria D.9, Beuzeboc P.10, Cormier L.11, Mongiat Artus P.12, De La Taille A.13, Roupret M.14, Salomon L.13, Soulié M.1, Mejean A.15, Rozet F.16

Institutes: 1CHU Rangueil, Dept. of Urology, Toulouse, France, 2St Jean Hospital, Dept. of Urology, Toulouse, France, 3CHU Lille, Dept. of Urology, Lille, France, 4CHU, Dept. of Urology, Lille, France, 5CHU, Dept. of Urology, Rennes, France, 6CHU, Dept. of Pathology, Tours, France, 7CHU St Louis, Dept. of Radiotherapy, Paris, France, 8CHU La Pitié Salpétrière, Dept. of Radiology, Paris, France, 9ICM, Dept. of Radiotherapy, Montpellier, France, 10Curie Institute, Dept. of Oncology, Paris, France, 11CHU, Dept. of Urology, Dijon, France, 12CHU St Louis, Dept. of Urology, Paris, France, 13CHU Mondor, Dept. of Urology, Créteil, France, 14CHU La Pitié Salpétrière, Dept. of Urology, Paris, France, 15HEGP, Dept. of Urology, Paris, France, 16IMM, Dept. of Urology, Paris, France, 17IUCT-O, Dept. of Statistics, Toulouse, France

Prognostic significance of vas deferens invasion after radical prostatectomy in patients with pathological stage T3b prostate cancer

By: Jang W.S.1, Han J.H.1, Kang Y.J.1, Yoon C.Y.1, Kwon J.K.1, Lee J.Y.1, Cho K.S.1, Ham W.S.1, Kim W.T.3, Kim Y.S.2, Choi Y.D.1

Institutes: 1Urological Science Institute, Yonsei University College Of Medicine, Dept. of Urology, Seoul, South Korea, 2National Health Insurance Corporation Ilsan Hospital, Dept. of Urology, Goyang, South Korea, 3Chungbuk National University College of Medicine, Dept. of Urology, Cheongju, South Korea

Level of education and mortality after radical prostatectomy

By: Fröhner M.1, Koch R.2, Propping S.1, Hübler M.3, Wirth M.3

Institutes: 1Technical University Dresden, Dept. of Urology, Dresden, Germany, 2Technical University Dresden, Dept. of Medical Informatics, Dresden, Germany, 3Technical University Dresden, Dept. of Anesthesiology, Dresden, Germany

Does neoadjuvant hormonal therapy stimulate cancer cell dissemination via increasing of lymph vessel size in prostate cancer patients?

By: Miyata Y., Hakariya T., Shida Y., Asai A., Yasuda T., Matsuo T., Ohba K., Sakai H.

Institutes: Nagasaki University Graduate School Of Biomedical Sciences, Nagasaki, Japan